Gene therapy to kill cancer moves a step closer to market – CNET
CNET |
Gene therapy to kill cancer moves a step closer to market
CNET A new era of treating disease has moved a step closer to reality in the United States. A Food and Drug Administration panel gave a thumbs-up Wednesday to a gene therapy that involves genetically engineering a patient’s T-cells to fight a particular … |
CNET |
Gene therapy to kill cancer moves a step closer to market
CNET A new era of treating disease has moved a step closer to reality in the United States. A Food and Drug Administration panel gave a thumbs-up Wednesday to a gene therapy that involves genetically engineering a patient’s T-cells to fight a particular … |
NPR |
‘Living Drug’ That Fights Cancer By Harnessing Immune System Clears Key Hurdle
NPR The new treatment is known as CAR-T cell immunotherapy. It works by removing key immune system cells known as T cells from the patient so scientists can genetically modify them to seek out and attack only cancer cells. That’s why some scientists refer … Cancer-fighting immunotherapy recommended for FDA approvalLocal 10 Novel cancer treatment wins endorsement of FDA advisersWashington Post Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com Chicago Tribune –Drug Discovery & Development –Reuters –FDA all 133 news articles » |
|
Stand Up To Cancer, St. Baldrick’s Foundation Hail Green Light for CAR T Cell Therapy for Leukemia
PR Newswire (press release) SU2C and the St. Baldrick’s Foundation, the largest private funder of childhood cancer research grants, have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy, especially investigating why some … |
Nature.com |
Engineered cell therapy for cancer gets thumbs up from FDA advisers
Nature.com This is in stark contrast to some other CAR-T trials that have, over the past year, reported the death of several patients from severe brain swelling. Novartis’ therapy is not identical to the CAR–T cells used in those trials, which were administered … |
|
FDA advisers endorse what could be 1st US gene therapy
WEAR CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancers. Millions of … |